Financials Xeriant, Inc.

Equities

XERI

US98422N1037

Aerospace & Defense

Market Closed - OTC Markets 03:57:31 2024-04-26 pm EDT 5-day change 1st Jan Change
0.0199 USD -0.50% Intraday chart for Xeriant, Inc. -0.50% +12.43%

Valuation

Fiscal Period: June 2020 2021 2022 2023
Capitalization 1 3.173 68.81 27.14 9.204
Enterprise Value (EV) 1 3.374 68.18 30.08 15.43
P/E ratio -3.42 x -34.3 x -1.93 x -1.25 x
Yield - - - -
Capitalization / Revenue - - - -
EV / Revenue - - - -
EV / EBITDA - - -2,735,175 x -7,527,233 x
EV / FCF -61,940,057 x -77,912,150 x -25,663,175 x 824,230,999 x
FCF Yield -0% -0% -0% 0%
Price to Book -102 x 36.9 x -165 x -2.43 x
Nbr of stocks (in thousands) 69,584 292,816 365,239 389,433
Reference price 2 0.0456 0.2350 0.0743 0.0236
Announcement Date 9/30/20 10/13/21 10/13/22 10/16/23
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: June 2019 2020 2021 2022 2023
Net sales - - - - -
EBITDA - - - -11 -2.05
EBIT 1 -0.092 -0.3627 -2.199 -11.01 -2.052
Operating Margin - - - - -
Earnings before Tax (EBT) 1 -0.0925 -0.6996 -2.703 -15.88 -7.097
Net income 1 -0.0925 -0.6996 -1.543 -13.3 -7.067
Net margin - - - - -
EPS - -0.0133 -0.006843 -0.0385 -0.0188
Free Cash Flow - -0.0545 -0.8751 -1.172 0.0187
FCF margin - - - - -
FCF Conversion (EBITDA) - - - - -
FCF Conversion (Net income) - - - - -
Dividend per Share - - - - -
Announcement Date 9/30/20 9/30/20 10/13/21 10/13/22 10/16/23
1USD in Million
Estimates

Balance Sheet Analysis

Fiscal Period: June 2019 2020 2021 2022 2023
Net Debt 1 0.03 0.2 - 2.94 6.23
Net Cash position 1 - - 0.63 - -
Leverage (Debt/EBITDA) - - - -0.2674 x -3.038 x
Free Cash Flow - -0.05 -0.88 -1.17 0.02
ROE (net income / shareholders' equity) - 2,150% -802% 1,408% 148%
ROA (Net income/ Total Assets) - -173% -196% -570% -178%
Assets 1 - 0.4041 0.7884 2.334 3.959
Book Value Per Share - -0 0.0100 -0 -0.0100
Cash Flow per Share - 0 0 0 0
Capex - - - 0.02 0
Capex / Sales - - - - -
Announcement Date 9/30/20 9/30/20 10/13/21 10/13/22 10/16/23
1USD in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Equities
  3. XERI Stock
  4. Financials Xeriant, Inc.